Nanobiotechnology and Nanomedicine Companies
(Links listed alphabetically)
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | All
Showing results 1 - 25 of 178
The firm commercializes a family of self-assembling nanoscale scaffolds called PuraMatrix. 3DM's materials assemble upon injection into nanofibers, serving as a scaffold for tissue regeneration.
Develops Nanobodies, antibody-derived therapeutic proteins that contain the unique structural and functional properties of naturally-occurring heavy-chain antibodies.
Accium offers laboratory services based on its Accelerator Mass Spectrometry platform used to detect 14C/12C ratios which provided 1,000 times more sensitivity than the most sensitive method available today such as LC/MS. It is now possible to trace biomolecule delivery in healthy subjects with low attomole sensitivity.
Develops in-vitro models of cell and tissue systems. They simulate the transport of substances and formulations across biological barriers, from which conclusions regarding permeability and absorption can be drawn.
The company has developed and produced superparamagnetic nanoparticles for in vitro diagnostic and life sciences.
Develops and to markets a novel, automated chip-based technology for mass spectrometry users with the microfluidics chip containing an array of nanoelectrospray nozzles.
Affymetrix GeneChip microarray technology is the industry-standard tool for analyzing complex genetic information. The GeneChip solution consists of oligonucleotide arrays, instruments to process and analyze the arrays, and software tools to manage and mine the data.
Akonni Biosystems is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems.
Altogen Biosystems develops polymer-, lipid-, and dendrimer-based transfection technology by applying expertise in molecular biology, combinatorial chemistry, and cell biology.
AMRI is a chemistry-based drug discovery, development and manufacturing company, focusing on small molecule prescription drugs.
AnaSpec, Inc. is a leading provider of integrated proteomics solutions for worldwide life science research. With a vision for innovation through synergy, AnaSpec offers expertise in three primary technologies: peptides, detection reagents, and combinatorial chemistry. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. In conjunction, AnaSpec provides premier custom services including peptide synthesis, antibody production, and assay development.
ANP's mission is to develop cutting-edge technology platforms at the nano/bio interface and apply them in market sectors such as diagnostics/biodetection, protein/drug discovery, therapeutics, chem/bio defense, and homeland security.
AnyGen develops bio-new drugs and essential materials, especially new drug candidates based on physiologically active peptides, biologically functional materials, and chemical nanomaterials.
The company develops biomedical nanoparticle technology and products for research and treatment of human disease. They are developing NanoElectroPlex™, a proprietary tissue selective nanoparticle platform technology based on biodegradable macromolecular carriers.
The company has developed enabling nanotechnologies for the production of protein nanoparticles, polymer nanospheres and phospholipid nanosomes for the enhanced delivery of drugs.
Aposense is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents based on the identification and targeting of cells undergoing apoptosis (programmed cell death).
Develops and manufactures micelle-like nanoparticulate encapsulation technology for applications in food, cosmetics, pharmaceuticals and biotechnology.
Develops a nanostructured material that stops bleeding almost instantly.
Arrayit Corporation empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
Arrogene is developing a new generation of diagnostic and therapeutic drugs based utilizing a family of new nano biopolymers.
Designs, engineers and fabricates coatings, capsules, and "Artificial Cells" from polymers called polypeptides by a method called layer-by-layer self-assembly (LBL).
A biotechnology company engaged in the development and delivery of novel protein and cellular based therapies through design of proprietary Biological Nano Particles.
Provides labelled and chemically modified oligonucleotide scaffolds for nanotechnology applications.
Attana AB develops and sells biosensors for analysis of biomolecular interactions. Attana's biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
This is a clinical-stage product-focused molecular imaging company that has assembled expertise and IP in the field of molecular brain imaging.